STOCK TITAN

JIN MED INTL LTD. - ZJYL STOCK NEWS

Welcome to our dedicated page for JIN MED INTL LTD. news (Ticker: ZJYL), a resource for investors and traders seeking the latest updates and insights on JIN MED INTL LTD. stock.

JIN MED INTL LTD (ZJYL) delivers innovative rehabilitation equipment and living aids designed to enhance mobility for individuals with disabilities. This news hub provides investors and healthcare industry professionals with timely updates on the company's operational developments, product innovations, and market strategies.

Access comprehensive coverage of financial results, product launches, and strategic partnerships related to ZJYL's wheelchair series, bathing aids, and respiratory support devices. Our curated news collection serves as an essential resource for tracking the company's progress in medical device manufacturing and international distribution networks.

Key updates include developments in assistive technology R&D, expansion of Japanese market operations, and quality control initiatives within ZJYL's manufacturing processes. All content is verified for accuracy to support informed decision-making about this rehabilitation equipment specialist.

Bookmark this page for centralized access to ZJYL's latest corporate announcements and industry analysis. Check regularly for updates reflecting the company's commitment to advancing mobility solutions through engineered medical devices.

Rhea-AI Summary

JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL), a leader in Assistive Technologies (AT) and manufacturer of wheelchairs and living aids, has announced the start of construction for its new manufacturing facility in Chuzhou City, Anhui Province, China. The facility, operated by JinMed (Anhui) Co., , will be an internationally standardized, innovative, and high-end wheelchair manufacturing plant.

The new facility is expected to strengthen JinMed's position in the AT industry with higher-level production lines and more innovative products. Targeted to operate in 2025, it will expand capacity for manual wheelchairs and introduce production lines for electric wheelchairs, electric scooters, micro hyperbaric chambers, and scientific cosmetic products.

CEO Wang Erqi stated that this development marks a major milestone for JinMed, aligning with their goal of 'global technology for the benefit of mankind' and demonstrating the company's commitment to industry leadership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
none
-
Rhea-AI Summary
JIN MEDICAL INTERNATIONAL LTD. (NASDAQ: ZJYL) has signed a preliminary MOU with Jiangsu Zhongjin Kanglu Information Technology Co., Ltd. to potentially acquire all or a partial stake in Zhongjin Kanglu, a company engaged in the medical equipment sharing business. The due diligence process is expected to be completed by December 31, 2023, with detailed negotiations for the potential acquisition commencing from March 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.92%
Tags
-
Rhea-AI Summary
JIN MEDICAL INTERNATIONAL LTD. (NASDAQ: ZJYL) announces the selection of its portable nano-thermal therapy bath for the 'Lao Le Hui' Assisted Bathing Project in Shanghai, aiming to provide compassionate care to disabled or semi-disabled elderly individuals. The Project plans to serve 100,000 individuals and train 2,000 bathing attendants over two years. JinMed will provide 1,000 sets of bath equipment and auxiliary medical devices to support the initiative, potentially leading to further commercialization of its bath products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.6%
Tags
none
Rhea-AI Summary
JIN MEDICAL INTERNATIONAL LTD. (NASDAQ: ZJYL) has secured orders of RMB 66 million for its innovative Micro-Hyperbaric Oxygen Chamber equipment, demonstrating trust from business partners. These chambers are designed for optimal therapeutic benefits, with Conlo Industrial Development (Shanghai) CO., LTD. placing substantial orders for 200 units of each chamber type. Anticipating robust demand, Conlo plans to deploy 10,000 oxygen chambers for humans and pets exclusively sourced from JinMed in the Chinese market over the next three years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.78%
Tags
none
-
Rhea-AI Summary
Jin Medical International received a notification from NASDAQ stating that it no longer complies with the minimum 300 public holders requirement for continued listing. The company has 45 days to submit a plan to regain compliance. If accepted, they may be granted an extension of up to 180 days to evidence compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.23%
Tags
none
-
Rhea-AI Summary
Jin Medical International expands into manufacturing lifestyle beauty products, collaborating with MIYAKO to develop three groundbreaking products. 600 orders received, demonstrating market recognition and trust.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.15%
Tags
none
Rhea-AI Summary
Jin Medical International Limited announces financial results for the six months ended March 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.98%
Tags
-
Rhea-AI Summary
Jin Medical International Limited (NASDAQ: ZJYL) celebrated its official listing on the New York Stock Exchange. The company, a leading provider of rehabilitation equipment, focuses on R&D and manufacturing high-end products for socially disadvantaged groups. It aims to prioritize technological innovation and expand its market share through continuous product development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.96%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
none
JIN MED INTL LTD.

Nasdaq:ZJYL

ZJYL Rankings

ZJYL Stock Data

147.15M
37.82M
75.84%
1.23%
0.22%
Medical Instruments & Supplies
Healthcare
Link
China
Changzhou